BCM
AMLX icon

Boxer Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Boxer Capital Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Hold
800,000
– – 1.46% 18
2025
Q4 		$9.66M Sell
800,000
-100,000
-11% -$1.36M 2.12% 14
2025
Q3 		$12.2M Sell
900,000
-325,000
-27% -$3.06M 3.9% 7
2025
Q2 		$7.85M Sell
1,225,000
-525,000
-30% -$2.55M 3.95% 9
2025
Q1 		$6.2M Hold
1,750,000
– – 1.86% 19
2024
Q4 		$6.62M Buy
+1,750,000
New +$8.23M 0.56% 38

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return